Stay updated on Dolutegravir vs Efavirenz in Pregnant Women Clinical Trial
Sign up to get notified when there's something new on the Dolutegravir vs Efavirenz in Pregnant Women Clinical Trial page.

Latest updates to the Dolutegravir vs Efavirenz in Pregnant Women Clinical Trial page
- Check4 days agoChange DetectedLocations section updated to add new site entries (Florida; South-East District; Minas Gerais; Maharashtra; Gauteng; KwaZulu-Natal; Western Cape; Bangkoknoi) and remove old location blocks, with a new revision tag (v3.3.3).SummaryDifference0.7%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedMinor wording updates to the Publications section clarify that publications are provided voluntarily by the person who enters information about the study and relate to the results, that publications are automatically filled in from PubMed, and may not always pertain to the study, and a new revision label (Revision: v3.3.2) was added. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check33 days agoChange DetectedRemoval of the government funding/operating status notice from the page; the study details and access to information remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check55 days agoChange DetectedNo significant changes detected on the study details page between the two screenshots.SummaryDifference0.3%

- Check76 days agoChange DetectedCore content updated with a government funding notice and a new version release (v3.2.0); previous v3.1.0 version tag removed.SummaryDifference2%

- Check84 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0, indicating a new release with potential updates or features. No other content changes are indicated.SummaryDifference0.0%

Stay in the know with updates to Dolutegravir vs Efavirenz in Pregnant Women Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dolutegravir vs Efavirenz in Pregnant Women Clinical Trial page.